Brooklyn, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC, founded in 1992, is a small nonprofit in the Diseases & Disorders sector that reported $483K in total revenue in fiscal year 2024.
To improve the quality of life for individuals and families living with sickle cell disease, and other inherited blood disorders.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $483,355 | $483,475 | 0.0% |
| Expenses | $483,415 | $296,095 | +0.6% |
| Net Income | $-60 | $187,380 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| TERESA DAVIS | PRESIDENT | 20.00 |
Officer
|
$0 | $0 | $0 |
| VIVIAN OKWUAGWU | SECRETARY | 20.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $483,355 | $483,415 | $66,890 | $-60 |
| 2023 | $421,315 | $484,025 | $45,761 | $-62,710 |
| 2023 | $262,347 | $249,880 | $12,769 | $12,467 |
| 2022 | $301,033 | $219,856 | $127,418 | $81,177 |
| 2021 | $245,519 | $203,218 | $127,376 | $42,301 |
| 2020 | $226,614 | $219,662 | $124,572 | $6,952 |
| 2019 | $248,103 | $209,404 | $126,619 | $38,699 |
| 2018 | $188,534 | $163,543 | $157,216 | $24,991 |
Compare SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC with other nonprofits in New York and across the country.